Product Information
ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) is a generic product labeled by American Regent, Inc., priced at $2.2455 per ML under NDC 00517760425. Its NADAC has been published 285 times since May 20, 2020.
FDA first approved this application on Jul 28, 1995. Its Orange Book therapeutic-equivalence code is AN.
Strength
200 mg/mL
Manufacturer
American Regent, Inc.NDC
00517760425
Classification
Generic
Dosage Form
INHALANT
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
ACETYLCYSTEINEApproval Type
Generic (ANDA)
FDA Application
ANDA072547FDA Approved
7/28/1995
TE Code
AN
On Market Since
10/1/1995
Pharmacological Classes
Price Statistics
The NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has been published 285 times since May 20, 2020, and over the history we have for it it has risen 14.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.2455 per ML |
|---|---|
| All-time high | $2.6444 (Oct 15, 2025) |
| All-time low | $1.6443 (Sep 23, 2020) |
| 52-week high | $2.6444 |
| 52-week low | $2.1633 |
| Median price | $2.1234 |
| Average price | $2.0794 |
| Largest weekly change | +32.7% (Aug 23, 2023) |
| Weeks tracked | 285 |
| Tracking since | May 20, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 47% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
American Regent, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
acetylcysteine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antidote class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?
The current National Average Drug Acquisition Cost (NADAC) for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION), manufactured by American Regent, Inc., is $2.2455 per ML (NDC 00517760425), effective Sep 30, 2026.
How has the price of ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) changed over time?
Over the history we have for it, the NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has risen 14.8%. It has been tracked across 285 weekly CMS publications since May 20, 2020.
What are the highest and lowest recorded NADAC prices for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?
Since May 20, 2020, the NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has ranged from a low of $1.6443 (Sep 23, 2020) to a high of $2.6444 (Oct 15, 2025), with a median of $2.1234 per ML.
Are there cheaper alternatives to ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ACETYLCYSTEINE 20% VIAL, is $1.1883 per ML — about 47% below ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION).
Who manufactures ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?
ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) (NDC 00517760425) is labeled by American Regent, Inc., and CMS classifies it as a generic product.